News
Performance
The creamy layer - amongst the top performing stocks
Valuation
Seems to be overvalued vs the market average
Growth
Lagging behind the market in financials growth
Profitability
Average profitability - not good, not bad
Entry point
The stock is in the overbought zone
Red flags
The stock has a moderate number of red flags
Go Pro! to unlock score, rank
and other metrics
How to use scorecard? Learn more
Bacil Pharma reports standalone nil net profit/loss in the September 2022 quarter
1 year ago•Business Standard
Bacil Pharma reports standalone net loss of Rs 0.08 crore in the September 2021 quarter
2 years ago•Business Standard